IDEXX Laboratorie receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
IDEXX Laboratories Inc (IDXX)
Assess today's live IDEXX Laboratories Inc (IDXX) share price, performance and insights using our live NASDAQ: IDXX stock exchange data.
Analyse the historical data and IDEXX Laboratories Inc share price performance charts on this page. Our technical summary section provides analysis on IDEXX Labs share price buy/sell indicators using real-time data (or discuss the IDEXX Labs (IDXX) stock price today with other investors in the IDEXX Labs NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ IDXX share price (ISIN: US45168D1046) to enhance your trading decisions with our free investment tools and resources.
What Is the IDEXX Laboratories Inc Share Price Today?
The IDEXX Labs share price today is 406.65.
What Is the Stock Symbol for IDEXX Laboratories Inc
The stock symbol (or 'ticker') for IDEXX Laboratories Inc is "IDXX."
What Stock Exchange Does IDEXX Laboratories Inc Trade On?
IDEXX Laboratories Inc is listed and trades on the NASDAQ stock exchange.
Is IDEXX Laboratories Inc a Good Stock to Buy?
Determining whether IDEXX Laboratories Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and IDEXX Laboratories Inc share price performance charts on this page. Our technical summary section provides analysis on IDEXX Labs share price buy/sell indicators using real-time data (or discuss the IDEXX Labs (IDXX) stock price today with other investors in the IDEXX Labs NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ IDXX share price (ISIN: US45168D1046) to enhance your trading decisions with our free investment tools and resources.
What Is the IDEXX Laboratories Inc Share Price Today?
The IDEXX Labs share price today is 406.65.
What Is the Stock Symbol for IDEXX Laboratories Inc
The stock symbol (or 'ticker') for IDEXX Laboratories Inc is "IDXX."
What Stock Exchange Does IDEXX Laboratories Inc Trade On?
IDEXX Laboratories Inc is listed and trades on the NASDAQ stock exchange.
Is IDEXX Laboratories Inc a Good Stock to Buy?
Determining whether IDEXX Laboratories Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Currency in USD
406.65
-4.84(-1.18%)
Closed·
Pre Market
406.650.00(0.00%)
·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
402.85
412.31
52 wk Range
356.14
548.88
IDXX Scorecard
Full Analysis
Management has been aggressively buying back shares
Earnings results expected in 9 days
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
402.85412.31
52 wk Range
356.14548.88
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
IDXX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Price Target
493.21
Upside
+21.29%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
4 analysts have revised their earnings downwards for the upcoming period
IDEXX Labs Company Profile
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, it offers diagnostic tests, services, and related instrumentation for manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
IDEXX Laboratories Inc SWOT Analysis
Market Leadership | Explore IDEXX's dominance in veterinary diagnostics, balancing declining visits with increased utilization and innovative product launches |
Financial Resilience | Despite market headwinds, IDEXX maintains robust profitability with a 60.7% gross margin and 7.2% revenue growth, showcasing its financial strength |
Growth Projections | Analysts forecast sustainable double-digit top-line growth for IDEXX, with price targets ranging from $481 to $630, reflecting optimistic long-term outlook |
Strategic Innovation | Delve into IDEXX's product development strategy, including the inVue Dx Analyzer and IDXX Cancer Dx, driving competitive advantage in a evolving market |
IDEXX Laboratories Inc Earnings Call Summary for Q3/2024
- Q3 organic revenue up 6%, EPS rose 11% YoY to $2.80; full-year guidance revised to 5.3%-6% growth
- CAG diagnostics recurring revenue growth adjusted to 5.8%-6.4%; total 2024 revenue forecast $3.865B-$3.890B
- Strong gross margins at 61.1%; customer retention over 97%; growth in premium instrument installed base
- Q4 organic growth projected at 3%; recurring revenue growth 3.5%-4%; long-term pet care spending outlook positive
- New product launches, including IDEXX inVue Dx Cellular Analyzer, expected to drive future growth
Last Updated: 01/11/2024, 13:22
Read Full TranscriptCompare IDXX to Peers and Sector
Metrics to compare | IDXX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIDXXPeersSector | |
|---|---|---|---|---|
P/E Ratio | 37.1x | −2.3x | −0.5x | |
PEG Ratio | 6.16 | 0.07 | 0.00 | |
Price/Book | 20.7x | 2.6x | 2.6x | |
Price / LTM Sales | 8.5x | 4.2x | 2.9x | |
Upside (Analyst Target) | 22.3% | 78.9% | 60.8% | |
Fair Value Upside | Unlock | 14.4% | 10.8% | Unlock |
Analyst Ratings
6 Buy
7 Hold
0 Sell
Ratings:
13 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 493.21
(+21.29% Upside)
Earnings
Latest Release
Feb 03, 2025
EPS / Forecast
2.62 / 2.39
Revenue / Forecast
954.28M / 933.38M
People Also Watch
FAQ
What Is the IDEXX Labs (IDXX) Stock Price Today?
The IDEXX Labs stock price today is 406.65
What Stock Exchange Does IDEXX Labs Trade On?
IDEXX Labs is listed and trades on the NASDAQ stock exchange.
What Is the Stock Symbol for IDEXX Labs?
The stock symbol for IDEXX Labs is "IDXX."
What Is the IDEXX Labs Market Cap?
As of today, IDEXX Labs market cap is 32.95B.
What is IDEXX Labs Earnings Per Share?
The IDEXX Labs EPS is 10.77.
What Is the Next IDEXX Labs Earnings Date?
IDEXX Labs will release its next earnings report on 30 Apr 2025.
From a Technical Analysis Perspective, Is IDXX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.